However, in the Indian cohort, differences between perampanel and placebo often did not reach statistical significance, unlike in the non‐Indian cohort, which may be attributable to smaller sample sizes in the former.
← all excerpts
Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of Phase II and Phase III double-blind and open-label extension studies in India.
1
—
—